Y4C-11164-20007
3 vaccinations
2 coded responses
35 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 217 / MD
- Registered
- 2021-01-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-15
Dose 1 — Moderna
-
2021-01-16
Registered in v-safe
- 2021-01-16
-
2021-01-17
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Swelling · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-20
Health check-in — days 1–6 daily, dose 1Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-01-22
Health check-in — day 7, dose 1Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
- 2021-01-29
- 2021-02-05
-
2021-02-12
Dose 2 — Moderna
-
2021-02-12
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-02-13
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Swelling, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-14
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-15
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-02-16
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness, Swelling · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-02-17
Health check-in — days 1–6 daily, dose 2Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-02-18
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Itching · Fever · Headache, Fatigue or tiredness, Rash, not including the immediate area around the injection siteAdult check-in
-
2021-02-19
Health check-in — day 7, dose 2Feeling: Good · Site: Itching · Headache, Rash, not including the immediate area around the injection siteAdult check-in
- 2021-02-26
- 2021-03-05
- 2021-03-13
- 2021-03-19
- 2021-03-26
- 2021-05-14
- 2021-08-13
-
2021-10-22
Dose 3 — Moderna
-
2021-10-24
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-10-25
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-10-26
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
- 2021-10-27
- 2021-10-28
- 2021-10-29
- 2021-11-05
- 2021-11-12
- 2021-11-19
- 2021-11-28
- 2021-12-03
- 2022-01-21
-
2022-04-24
Survey response — 6 months, dose 3MedDRA: Lyme disease — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: LymesMedDRA releases: 2024-11 · check-in free text available
-
2022-10-24
Survey response — 12 months, dose 3MedDRA: Pre-existing disease — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationFree text: Long covidMedDRA releases: 2024-11 · check-in free text available
-
2022-10-24
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2022-10-26
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-15 | Moderna | |
| 2 | 2021-02-12 | Moderna | |
| 3 | 2021-10-22 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-10-24 | Unsuccessful |
Free text
Release 11 — 6 months, dose 3
Symptoms: Lymes
Release 12 — 12 months, dose 3
Symptoms: Long covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Lyme disease | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release